BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  BioMidwest

  Study Shows Development of Young Cells Could be New Option in Cancer Care

  Washington University School of Medicine in St. Louis released a new study about the effectiveness of immunotherapy based on the age of the cells used.

  March 25, 2020

   · 

  2 min read

   · 

  Michelle Brugioni
• 

  Business

  Redpin Launches with $15.5 Million Series A to Focus on Pain and Epilepsy

  Based in New York City, Redpin has a proprietary chemogenetics platform for targeted cell therapies.

  March 25, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Vir Biotech IDs Two Antibodies That Could Be Effective in Preventing and Treating COVID-19

  The lead antibody’s ability to neutralize the SARS-CoV-2 live virus has been confirmed in two different laboratories.

  March 25, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Kallyope Prepares to Enter the Clinic Following $112 Million Financing Round

  Kallyope Chief Executive Officer Nancy Thornberry said the company’s journey to becoming a “first-mover in the gut-brain axis space” is coming to fruition.

  March 25, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Truvian Sciences’ Point-of-Care Diagnostics Could Provide Long-Term Solution for Future Pandemics

  “These kinds of situations remind people how important diagnostics are,” Hawkins told BioSpace in an interview.

  March 25, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  FDA

  PerkinElmer Joins Growing List of Companies with Approved COVID-19 Test Kits

  PerkinElmer is the 16th company to receive an EUA for COVID-19 testing.

  March 25, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  BioSpace Global Roundup, March 26

  Pharma and life sciences companies from across the globe provide updates on their pipelines and business practices.

  March 25, 2020

   · 

  5 min read

   · 

  Alex Keown
• 

  FDA

  FDA OKs Convalescent Plasma for Treating Critically Ill COVID-19 Patients

  The same day that New York Gov. Andrew Cuomo announced the initiation of a clinical trial using blood plasma from patients who have recovered from COVID-19, the U.S. Food and Drug Administration announced wider support for the practice.

  March 25, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Biopharma Industry News for March 25: Update on the Novel Coronavirus

  A summary of daily biopharma industry news. Please check out stories that are trending on March 25, 2020.

  March 25, 2020

   · 

  7 min read

   · 

  BioSpace Editorial Staff
• 

  BioCapital

  In Other (Biopharma) News: This Week’s Non-Coronavirus Stories

  BioSpace takes a quick look at some recent, key industry news that is not related to the coronavirus.

  March 25, 2020

   · 

  4 min read

   · 

  Alex Keown